The HDAC inhibitor SB939 overcomes resistance to BCR-ABL kinase Inhibitors conferred by the BIM deletion polymorphism in chronic myeloid leukemia

由 Rauzan M., Chuah C.T.H., Ko T.K., Tiong Ong S.
出版 2020

BIM Deletion Polymorphism Profiling Complements Prognostic Values of Risk Scores in Imatinib-treated Asian Chronic Myeloid Leukemia Patients

由 Hein Than, Weng Kit Lye, Colin Sng, John Allen, S., Tiong Ong, Charles Chuah
出版 2019

Identification of drugs for leukaemia differentiation therapy by network pharmacology

由 Eleni G Christodoulou, Lin Ming Lee, Kian Leong Lee, Tsz Kan Fung, Eric So, Enrico Petretto, S. Tiong Ong, Owen JL Rackham
出版 2020